RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody

NCT06481553 · clinicaltrials.gov ↗

UNKNOWN

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage IV

Interventions

DRUG: first line treatment

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences